This is a good example of why "purity looks fine" is not the same as "label claims are accurate." Tesamorelin: Large Sample Volume, Very Wide Quantity Divergence Finnrick has tested 404 Tesamorelin samples from 45 vendors (7 May 2025 to 20 May 2026)
For CY 2026, consistent with our established policy, we proposed in the CY 2026 OPPS/ASC proposed rule (90 FR 33533) that the HCPCS codes that would be effective October 1, 2025, would be flagged with comment indicator N1 in Addendum B to the CY 2026 OPPS/ASC final rule with comment period to indicate that we have assigned the codes to interim OPPS status indicators for CY 2026
Treatments like intracavernous injections, topical alprostadil, or intraplaque verapamil are invasive
While these bioactive compounds offer numerous health benefits at low doses, high doses or prolonged use can lead to adverse effects, including organ-specific toxicity, pro-oxidant activity, and drug interactions